Clinical Trial Update: Safety Study of GNbAC1 in Multiple Sclerosis Patients [Phase 2]

View source ↗

Summary

Phase 2 safety study of GNbAC1 in patients with Multiple Sclerosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• GNbAC1

Snippet

Sponsor: GeNeuro Innovation SAS | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED